ResearcherStiftung CharitéActive in the last 2 years

Matthias Glanemann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5431-6348; OpenAlex author ID A5006852883. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sven‐Thorsten Liffers · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Theodoros Kolokotronis · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Marie Buchholz · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Britta Majchrzak‐Stiller · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Waldemar H. Uhl · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Chris Braumann · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Philipp Höhn · 1 shared paper, 2024 · strength 0.17
- Paper Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as… DOI 10.3390/cancers16152726 ↗
Philipp R. SCHERBER · 1 shared paper, 2022 · strength 0.16
- Paper Role of biliary drainage before pancreatoduodenectomy for pancreatic adenocarcinoma: a retrospective study. DOI 10.23736/s2724-5691.22.09414-x ↗
Marcus Bahra · 1 shared paper, 2012 · strength 0.03
- Paper Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. DOI 10.1245/s10434-011-2041-4 ↗
Carsten Kamphues · 1 shared paper, 2012 · strength 0.03
- Paper Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. DOI 10.1245/s10434-011-2041-4 ↗
Frederick Klauschen · 1 shared paper, 2012 · strength 0.03
- Paper Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. DOI 10.1245/s10434-011-2041-4 ↗
Albrecht Stenzinger · 1 shared paper, 2012 · strength 0.03
- Paper Postoperative complications deteriorate long-term outcome in pancreatic cancer patients. DOI 10.1245/s10434-011-2041-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.